Type 1 Diabetes Champion Susan Solomon Passes Away
Breakthrough T1D mourns the passing of Susan Solomon
Glucagon: Your Friend in Low Places
Glucagon. It’s a word familiar to people with T1D, yet one most hope to avoid discussing. But what is glucagon…
FDA Authorizes Omnipod 5 for Ages 2+ in Children with Type 1 Diabetes
The FDA authorized the Insulet Omnipod 5, the world’s first tubeless, wearable system, for children 2+, using an algorithm that…
Study Shows No Link Between T1D Diagnoses and COVID-19
JDRF-funded researchers in Colorado and Germany found no link between COVID-19 and type 1 diabetes in children and adolescents ages…
A New Tool to Accurately Diagnose Type 1 in Adults
Misdiagnosing adults with type 1 diabetes (T1D) is an all-too-common problem that can have tragic consequences. Breakthrough T1D and IQVIA…
Diabetes Research in Pediatrics? The International Society Has Your Back
Learn more about the recipients of the International Society for Pediatrics and Adolescent Diabetes (ISPAD)-Breakthrough T1D Fellowships here!
Breakthrough T1D Timeline: Stem Cell Therapies
Stem cells have the potential to lead to treatments for type 1 diabetes, but it has taken Breakthrough T1D more…
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
At the ADA’s Scientific Sessions, Breakthrough T1D scientists presented on some of the most important topics, all with the same…
Breakthrough T1D Heads—In Person!—to ADA’s 82nd Scientific Sessions
From June 3-7, diabetes researchers around the world will gather—in person!—at the American Diabetes Association’s 82nd Scientific Sessions. #JDRFxADA
FDA Approved! Abbott FreeStyle Libre® 3 Continuous Glucose Monitor, Ages 4+
The FDA cleared the FreeStyle Libre 3 continuous glucose monitor (CGM) for children and adults ages 4 and up with diabetes
